---
figid: PMC6627629__marinedrugs-17-00345-g006
figlink: /pmc/articles/PMC6627629/figure/marinedrugs-17-00345-f006/
number: Figure 6
caption: Proposed mechanisms for fucoidan-mediated inhibition of osteoclastogenesis.
  During RANKL stimulation, fucoidan inhibits Akt phosphorylation leading to GSK3
  and PTEN activation, and calcium/calcineurin cascade, which ultimately suppresses
  nuclear translocation of NFATc1 and osteoclastogenesis-related gene expression,
  which in turn attenuates osteoclast differentiation.
pmcid: PMC6627629
papertitle: Fucoidan Prevents RANKL-Stimulated Osteoclastogenesis and LPS-Induced
  Inflammatory Bone Loss via Regulation of Akt/GSK3Î²/PTEN/NFATc1 Signaling Pathway
  and Calcineurin Activity.
reftext: Sheng-Hua Lu, et al. Mar Drugs. 2019 Jun;17(6):345.
pmc_ranked_result_index: '166179'
pathway_score: 0.9668064
filename: marinedrugs-17-00345-g006.jpg
figtitle: Proposed mechanisms for fucoidan-mediated inhibition of osteoclastogenesis
year: '2019'
organisms: Homo sapiens
ndex: 65e03b72-decc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6627629__marinedrugs-17-00345-g006.html
  '@type': Dataset
  description: Proposed mechanisms for fucoidan-mediated inhibition of osteoclastogenesis.
    During RANKL stimulation, fucoidan inhibits Akt phosphorylation leading to GSK3
    and PTEN activation, and calcium/calcineurin cascade, which ultimately suppresses
    nuclear translocation of NFATc1 and osteoclastogenesis-related gene expression,
    which in turn attenuates osteoclast differentiation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - TNFSF11
  - AKT2
  - PPP3CA
  - AKT3
  - PPP3CB
  - PPP3CC
  - PPP3R1
  - PTEN
  - PPP3R2
  - GSK3B
  - NFATC1
  - TNFRSF11A
  - Ca
  - Ser
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RANKL
  symbol: RANKL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF11
  entrez: '8600'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: NFATC
  symbol: NF-ATC
  source: hgnc_alias_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: RANK
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
- word: NFATC1
  symbol: NFATC1
  source: hgnc_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
chemicals:
- word: Ca
  source: MESH
  identifier: D002118
- word: Ser
  source: MESH
  identifier: C530429
diseases: []
---
